Ayurcann Holdings Corp.
AYURF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $31 | $25 | $12 | $9 |
| % Growth | 23.7% | 101.4% | 33.1% | – |
| Cost of Goods Sold | $21 | $17 | $9 | $7 |
| Gross Profit | $10 | $8 | $4 | $2 |
| % Margin | 32.7% | 33.6% | 29.5% | 23.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $6 | $6 | $6 |
| SG&A Expenses | $12 | $11 | $8 | $6 |
| Sales & Mktg Exp. | $5 | $4 | $2 | $0 |
| Other Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Expenses | $13 | $12 | $9 | $6 |
| Operating Income | -$3 | -$3 | -$5 | -$3 |
| % Margin | -9.1% | -12.9% | -42.8% | -35.5% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$4 | -$5 | -$3 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$3 | -$4 | -$5 | -$3 |
| % Margin | -11.2% | -15.8% | -42.5% | -32.9% |
| EPS | -0.013 | -0.022 | -0.035 | -0.026 |
| % Growth | 41.5% | 36.7% | -35.6% | – |
| EPS Diluted | -0.013 | -0.022 | -0.035 | -0.026 |
| Weighted Avg Shares Out | 195 | 177 | 150 | 119 |
| Weighted Avg Shares Out Dil | 195 | 177 | 150 | 119 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$2 | -$2 | -$4 | -$3 |
| % Margin | -5.9% | -8% | -33.2% | -31.7% |